Breast Cancers With Discordant Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization-Positive (Group 1) and Immunohistochemistry-Negative (0/11) Results Following American Society of Clinical Oncology/College of American Pathologists Guideline.
Saved in:
| Title: | Breast Cancers With Discordant Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization-Positive (Group 1) and Immunohistochemistry-Negative (0/11) Results Following American Society of Clinical Oncology/College of American Pathologists Guideline. |
|---|---|
| Authors: | Wilcock, Diane1, Jedrzkiewicz, Jolanta1,2, Cleary, Allison S.1,2, Beech, Cameron1,2, Gulbahce, H. Evin1,2 evin.gulbahce@path.utah.edu |
| Source: | Archives of Pathology & Laboratory Medicine. Jul2026, Vol. 150 Issue 7, p503-512. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
